Ruoli Chen r.chen@keele.ac.uk
Pharmacological properties of rutin and its potential uses for Alzheimer’s disease.
Chen, Ruoli; Hassan, Halimatu; Rawlinson, Charlotte; Morgan, David
Authors
Halimatu Hassan
Charlotte Rawlinson
David Morgan d.g.a.morgan@keele.ac.uk
Abstract
Rutin, a flavonoid with a wide range of biological activities, has a long history of use in nutritional supplements owing to its action against oxidative stress, inflammation, and hyperglycemia. Because of its pharmacological properties such as antioxidant, antiapoptosis, antiinflammation, rutin is proposed to treat Alzheimer’s disease (AD). AD is a complex, multi-factorial neurodegenerative disease, and is characterized by neuronal atrophy of brain tissue. One of the pathological hallmarks of AD is the aggregation of soluble ß amyloid (Aß) into fibrillary deposits. Aß aggregation induces neurotoxicity, oxidative stress and neuro-inflammation. In this review, we discussed the preclinical evidence on the antioxidant, antiapoptosis and anti-inflammatory proprieties of rutin, and the application of rutin in AD preclinical models. Rutin, delivered via oral and intraperitoneal routes, has been shown to functionally modify the cognitive and behavioural symptoms of AD in vivo due to its ability to cross the blood-brain barrier and act as both an antioxidant and an anti-inflammatory agent in the brain. Rutin attenuates oxidative stress, decreases the production of nitric oxide (NO) and proinflammatory cytokine and inhibits Aß aggregation and cytotoxicity. Further studies to improve its bioavailability and investigations into its protective activities in AD would provide a concrete foundation for the use of rutin in clinical trials.
Citation
Chen, R., Hassan, H., Rawlinson, C., & Morgan, D. (2020). Pharmacological properties of rutin and its potential uses for Alzheimer’s disease. Journal of Experimental Stroke and Translational Medicine, 13(2), 1-12
Journal Article Type | Article |
---|---|
Acceptance Date | Feb 2, 2020 |
Publication Date | Apr 8, 2020 |
Journal | Journal of Experimental Stroke and Translational Medicine |
Print ISSN | 1939-067X |
Publisher | OMICS Publishing Group |
Peer Reviewed | Peer Reviewed |
Volume | 13 |
Issue | 2 |
Pages | 1-12 |
Publisher URL | https://www.openaccessjournals.com/abstract/pharmacological-properties-of-rutin-and-its-potential-uses-for-alzheimers-disease-14592.html |
Files
pharmacological-properties-of-rutin-and-its-potential-uses-for-alzheimers-disease.pdf
(440 Kb)
PDF
Publisher Licence URL
https://creativecommons.org/licenses/by-nc/4.0/
You might also like
Proteomic analysis of age-related changes in ovine cerebrospinal fluid
(2018)
Journal Article
Discovery of a series of 2-(pyridinyl) pyrimidines as potent antagonists of GPR40
(2015)
Journal Article
Identification, optimization, and pharmacology of acylurea GHS-R1a inverse agonists
(2014)
Journal Article
Downloadable Citations
About Keele Repository
Administrator e-mail: research.openaccess@keele.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2024
Advanced Search